{"title":"[Transgender individuals and cardiovascular risk: what should the cardiologist know].","authors":"Antonia Mannarini, Maria Teresa Manes, Giuseppe Ciliberti, Daniela Pavan, Georgette Khoury, Daniela Aschieri, Angela Beatrice Scardovi, Noemi Bruno, Sara Cocozza, Maura Francese, Claudio Bilato, Giovanna Geraci, Furio Colivicchi, Massimo Grimaldi, Fabrizio Oliva","doi":"10.1714/4650.46647","DOIUrl":null,"url":null,"abstract":"<p><p>Cardiovascular risk estimation in transgender people is an emerging research area with significant clinical implications. Healthcare for transgender people is challenging, as it encompasses the impact of hormone therapies, social inequalities, and chronic stress associated with potential discrimination. In fact, these factors may differently influence cardiovascular risk as compared to the cisgender population, although current evidence is still limited. The aim of this paper was to provide an overview of current knowledge about cardiovascular disease in transgender individuals in order to promote an evidence-based approach for this population and, finally, health equality in cardiovascular disease management.</p>","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"27 3","pages":"182-190"},"PeriodicalIF":1.5000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Giornale italiano di cardiologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1714/4650.46647","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Cardiovascular risk estimation in transgender people is an emerging research area with significant clinical implications. Healthcare for transgender people is challenging, as it encompasses the impact of hormone therapies, social inequalities, and chronic stress associated with potential discrimination. In fact, these factors may differently influence cardiovascular risk as compared to the cisgender population, although current evidence is still limited. The aim of this paper was to provide an overview of current knowledge about cardiovascular disease in transgender individuals in order to promote an evidence-based approach for this population and, finally, health equality in cardiovascular disease management.